Results 141 to 150 of about 8,953 (160)

November 10th 2014 [PDF]

, 2014
CSUSB
core  

Updates in Diagnostic Techniques and Experimental Therapies for Diffuse Intrinsic Pontine Glioma. [PDF]

Cancers (Basel)
McVeigh L, Patel T, Miclea M, Schwark K, Ajaero D, Momen F, Clausen M, Adam T, Aittaleb R, Wadden J, Lau B, Franson AT, Koschmann C, Marupudi NI.   +13 more
europepmc   +1 more source

From Molecular Alterations to the Targeted Therapy: Treatment of Thalamic Glioma in Pediatric Patients. [PDF]

Int J Mol Sci
Yilmaz Y.
europepmc   +1 more source

Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer. [PDF]

NPJ Precis Oncol
Day ZI, Roberts-Thomson S, Nouri YJ, Dalton NS, Wang SS, Davenport A, Ludlow LE, Hulett MD, Cross RS, Jenkins MR.   +9 more
europepmc   +1 more source

Reduced EZH1/2 expression in imipridone-treated cells correlates with synergy following combinations with EZH1/2 or HDAC inhibitors in diffuse glioma and other tumors. [PDF]

Am J Cancer Res
Zhang Y, Huntington KE, Seyhan AA, Tapinos N, Lulla RR, Monje M, Wong ET, Chen CC, El-Deiry WS.   +8 more
europepmc   +1 more source

Cellular immunotherapies for central nervous system cancers. [PDF]

Neurooncol Adv
Scott BJ, Monje M.
europepmc   +1 more source

Pharmacological Phase I Clinical Trials in Pediatric Brain Tumors (1990-2024): A Historical Perspective. [PDF]

Oncol Res
Scarpitta R, Cappello E, Cangialosi A, Gori V, Luca G, Gori G, Bocci G.   +6 more
europepmc   +1 more source

Spinal Metastases in Diffuse Intrinsic Pontine Glioma: A Rare Presentation of Rapid Neurological Decline. [PDF]

Cureus
Markey GE, Boggula R, Hammoud A, Miller SR.   +3 more
europepmc   +1 more source